AMPE
Ampio Pharmaceuticals, Inc.
Set alert
- YTD
- +3,421.15%
- 1 year
- +3,421.15%
- Open
- 0.0052
- Prev close
- 0.1831
- Mkt cap
- 207.88K
- Vol
- 334
- Avg vol
- 0
- EPS
- -722.91
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.0052
- High
- 0.0052
- Forward P/E
- -3.39
- Beta
- 1.95
- Short ratio
- 0.31
- Inst. own
- 4.19%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Dec 24, 2024
- 50-d avg
- 1.49
- 200-d avg
- 2.82
- 1y target
- 0.00
Discussion (62)
Sign in to join the discussion
$AMPE ➡️$SMFL??
Allarity Therapeutics Inc.'s (NASDAQ: ALLR) announced that data of DRP companion diagnostic for Dovitinib has been published, noting that it demonstrated an ability to identify advanced renal cell carcinoma patients that have improved clinical benefit from dovitinib treatment, as compared to unselected patients. Shares closed up 16% at $1.85.
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) announced that it will acquire Acer Therapeutics (NASDAQ: ACER) for approximately 2.96 million shares of Zevra stock and up to an additional $76 million in a series of potential cash payments pursuant to non-transferable Contingent Value Rights (CVRs). Zevra shares closed down 4% at $5.07. Acer shares closed up 110% at $1.28.
Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) announced that it will effect a 1-for-22 reverse stock split of its outstanding common stock. This will be effective for trading purposes as of the commencement of trading on Friday, September 1, 2023. Shares closed down 28% at $0.2.
Peak Bio, Inc. (OTC PK: PKBO) announced its up-listing from the OTC Pink Market to the OTCQB Venture Market effective today at market open. Shares closed down 7% at $0.37.
Ampio Pharmaceuticals, Inc. (NYSE: AMPE) announced a 20-to-1 reverse stock split of its stock. The reverse stock split will become effective at 4:01 pm ET on September 11, 2023. Shares closed up 12% at $0.2.
Take your profit and come to $VS✈️✈️✈️✈️✈️
Same old song and dance for this POS